CardioBrief

One-stop source for cardiology news and links

Main menu

Skip to content

Home
About
CardioBrief Rebel Mouse
- The Controversy Over The TACT Chelation Trial

Search for:

November 12, 2011

The AHA Starts on Sunday ^Reply

by Larry Husten • Uncategorized

Look for AHA coverage from Orlando starting Sunday morning at 8 AM.

About these ads

Share this page:

Twitter
Email
Facebook
LinkedIn
Print
Digg
Reddit
StumbleUpon
Google +1
Tumblr

Like this:

Like Loading...

Post navigation

Controversy Over Cholesterol Testing for Children

TRACER: Novel Antiplatelet Vorapaxar Runs Into Trouble in ACS

What do you think? Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

Notify me of follow-up comments via email.

Notify me of new posts via email.

Note to Readers: A Time For Change

Click here to read about important new changes to CardioBrief.

Follow CardoBrief Via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 6,464 other followers

Follow CardioBrief via Twitter

Follow @cardiobrief

Follow CardioBrief VIA RSS

CardioBrief Tweets

I had a random lunch encounter with Mommy bloggers: thelilmamas.com yfrog.com/g0rb4yfj 16 hours ago
RT @adamfeuerstein: $AMRN - No Vascepa NCE decision... again. 18 hours ago
Thoratec wins FDA nod for HeartMate controller - FierceMedicalDevices: fiercemedicaldevices.com/story/thoratec… 18 hours ago
@adamhewitt198 @fivethirtyeight @bengoldacre Politicians lie to others. Pharma Execs/MDs lie to themselves. 22 hours ago
@Richard56 And what about the lack of expression on the faces of the Pieros? 23 hours ago
1. Crestor 2. Diovan 3. Lipitor 4. Zetia 5. Benicar 6. Micardis 7. Avapro 8. Vytorin 9. Blopress 10. Tracleer 1 day ago
FiercePharma Top 10 Cardio Drugs 2012: fiercepharma.com/special-report… 1 day ago
Kenneth Mahaffey quits DCRI for Stanford | theheart.org theheart.org/article/154081… 1 day ago
Congrats to Harlan Krumholz, well-deserved AHA QCOR award winner. ow.ly/l6dWt >I'm proud to work with him on CardioExchange 1 day ago
Smith: When I was “doing the hippy trail” in 1973 my friend passed out when an Indian doctor took my blood pressure. 1 day ago
Richard Smith's BMJ blog: Reclaiming blood pressure from doctors blogs.bmj.com/bmj/2013/05/16… 1 day ago
Half of researchers have reported trouble reproducing published findings: MD Anderson survey wp.me/pYKlt-3Gs via @wordpressdotcom 1 day ago
Astonishing that there were no criminal prosecutions in the Ranbaxy case. If ever it was justified… 2 days ago
"Every single [FDA] inspector that went to India said they would never take a Ranbaxy drug" 2 days ago
Remarkably, Ranbaxy is in a stronger position now in the U.S. than it was before its entanglement with the FDA. 2 days ago
...supervisors who had supposedly overseen critical manufacturing steps weren't even at the plant on the days they signed off on the tests. 2 days ago
if the drugs were an ongoing threat, why hadn't the FDA stopped Ranbaxy from selling them? 2 days ago
… "Who cares?" he said, according to Spreen. "It's just blacks dying." 2 days ago

Follow @cardiobrief

CardioBrief Classics

Coca-Cola, The Olympic Torch, And The American College Of Cardiology

Stem Cell Therapy Company Hypes Preliminary Results

Good Science/Bad Science: Contrasting Papers On Dietary Compositon In JAMA And BMJ

Subway Meals Get American Heart Association Endorsement

This Week In Medicine: Stop Exercising and Eat Chocolate!

You Know Nothing, Dr. Snow: Why Medicine Can’t Be More Like Facebook

Politics and Transcatheter Aortic Valve Replacement

Half the News That’s Fit To Print: NY Times On ECG Screening For Student Athletes

New Perspective on the Dutch Cardiovascular Research Scandal

Mark Midei Can’t Get a Job Taking Blood Pressure At A Walmart

And the 2012 Award For the Most Dumbass Drug Promotion Goes To…

You Know Nothing, Dr. Snow: Why Medicine Can’t Be More Like Facebook

Politics and Transcatheter Aortic Valve Replacement

Half the News That’s Fit To Print: NY Times On ECG Screening For Student Athletes

Mark Midei Can’t Get a Job Taking Blood Pressure At A Walmart

Guest Post: More Lessons From the Riata ICD Lead Recall

Japanese Researcher With Harvard Connections Retracts 3 Articles in AHA Journals

Lancet Editor Richard Horton Tweets Dark View of Contemporary Medicine

Resveratrol and Fraud

Director of UConn CV Research Center Accused of Scientific Misconduct

2011 in Review: Rivaroxaban, Sapien, Mark Midei, Conflicts of Interest, and Much More

Nissen and Topol Clash Over Genetics and Personalized Medicine

Ray of Light for the Physician Payment Sunshine Act

Letter From Jail: A Cautionary Tale

One More Thought About Lipitor

Experts Clash Over Interpretation and Value of AIM-HIGH

Controversy Over Cholesterol Testing for Children

CardioBrief Poll: Should the ACC Train Industry Reps?

Daily Show Asks Why the AHA Killed a Bill Encouraging Healthy Behavior

National Lipid Association Expert Panel Has Many Deep Ties To Industry

Industry & Medicine: It’s Complicated

Easy Come, Easy Go? ESC To Review Dronedarone’s Role in AF Guidelines

The Pen Is Mightier Than the Scold

CNN Documentary Promises Screening and Vegan Diet Can Eliminate Heart Attacks

CNN, ABC, and NBC Dumb Down the News About CV Screening

US Senate Unanimously Endorses Campaign Against Atrial Fibrillation

Less May Be More, But Stents Are Neither Good Nor Bad

The Voice of the Patient: Time To Bring Out the Muzzle?

New Concerns Raised About Withdrawn Archives Meditation Paper

Archives Decides At Last Minute Not to Publish a Scheduled Paper

Part 2: The National Lipid Association And Industry

Part 1: The National Lipid Association and the FH Guidelines

Understanding Risk: Tricky Business

ACC CEO Jack Lewin Provides The Argument Against Industry Money

The ACC Counts Down To Launch Of New Satellites

Scientific Fraud Found In Wayne Alexander’s Research Group At Emory

$50K: The Price For A VIP Dinner For 2 With The Cleveland Clinic CEO

Evidence: The Weak Link Of Evidence-Based Medicine

Taking Medical Advice From Peggy Fleming?

The ACC Wants You To Know That Nothing Is Rotten In The State Of Maryland

An Embargo Becomes A Public Relations Tool

PROTECT II: Who Will Protect Us From The Protectors?

GRAVITAS Published: Who Gets To Weigh In On the Results?

WebMD: the 800 Pound Gorilla in the Room

Some Things Don’t Go Better With Coke

ACC and HRS Downplay Data From Their Own Registry

Dangling Doctors In Front of Journalists

Spinning Out of Control: Another Look at the PROTECT II Press Release

Questions Raised About Compensation and Conflicts at Duke

SHARP: A Tale of Two Press Releases

Will This Be the HDL Decade? REVEAL Revealed, Mixed Results for Apo-A1

CardioExchange at the AHA: A New Voice Emerges

Top New York City Interventional Cardiologists Now Making $3 Million a Year

The Plot Thickens in the Case of the Exploding ICD

Red light or green light for AAA screening?

Blue light special: AAA screening at Kmart in the disease-mongering aisle

The rise of the ESC: is the ESC anti-American or pro-industry?

Dronedarone and ticagrelor speed into ESC guidelines

The debate over CME and industry influence continues

Avandia aftermath: who are the winners and losers?

Debating medical promotion and education

Why is there a red dress on diet Coke cans?

SHAPE shifting: transforming guidelines into a business venture

Why was an Abbott marketing study published in the American Journal of Cardiology?

At the Dallas valve meeting even the faculty is for sale

A missing piece of the Multaq puzzle finally appears: DIONYSOS published to little fanfare

EHJ editors rebuffed GSK efforts to suppress Nissen editorial on rosiglitazone

“Is it safe?”

Why we shouldn’t kill all the lawyers just yet

Why is there a red dress on diet Coke cans?

Sunday at the AHA: ARBITER’s wild roller coaster ride in Orlando

Cardiology $$$: Mt Sinai’s Samin Sharma tops Columbia’s Moses

Residual Risk Reduction Initiative: promotion or education?

Editorial: the incompetence of the FDA

Editorial: SHAPE is skating on thin ice

Extreme cardiology culture: Califf, Harrington, Topol & Teirstein

October thought experiment: suppose the World Series were covered like the Nobel Prize

Live AF ablation broadcast on Today Show: what’s wrong with this picture?

More Multaq: Prystowsky whack-a-mole, ACC responds, Sanofi overtures to EPs

Pieces of a puzzle: Multaq, Sanofi, ACC, HRS, Prystowsky, AF Guidelines

Email Subscription

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 6,464 other followers

Follow on Twitter

Follow @cardiobrief

My Google Plus Profile

Edward J. Schloss MD
Larry Husten

Top Posts

Instagram for Heart Attacks: iPhone App Speeds ECG Transmission To Hospital
Salt Report From IOM Sparks Much Heat, Only A Little Light
Phentermine/Topiramate Combination Yields Significant Weight Loss
Lilly and Daiichi Sankyo Pull The Trigger and Kill Prasugrel Study
About
Anticoagulation Update: New Agent For Urgent Anticoagulation Reversal, Pradaxa Label Revised
Heart Failure Death Statistics: Don’t believe what you read on the internet
Novel Leadless Pacemaker Makes Debut At HRS 2013
Top New York City Interventional Cardiologists Now Making $3 Million a Year
ACC and AHA Release New PCI and CABG Guidelines
FDA Approves Azilsartan Medoxomil (Edarbi) for High Blood Pressure
Pradaxa (dabigatran) Pricing Starts to Emerge

Archives

Meta

Register
Log in
Entries RSS
Comments RSS
WordPress.com

Email Subscription

Enter your email address to subscribe to CardioBrief and receive notifications of new posts by email.

Join 6,464 other followers

Follow on Twitter

Follow @cardiobrief

Archives

Recent Comments

	Cardiology EP Doc on Heart Rhythm Society Advising…
	eduardo on Resveratrol and Fraud
	HEPARIN BASED T1 TRE… on Bruise Control: Continued Warf…
	Larry Husten on Our Limitless Capacity For…
	Alan Averson on Our Limitless Capacity For…

Meta

Register
Log in
Entries RSS
Comments RSS
Blog at WordPress.com.

Blog at WordPress.com. | Theme: Newsy by Automattic. Design by Themify.

Follow

Follow “CardioBrief”

Get every new post delivered to your Inbox.

Join 6,464 other followers

Powered by WordPress.com

Send to Email Address Your Name Your Email Address

Cancel

Post was not sent - check your email addresses!

Email check failed, please try again

Sorry, your blog cannot share posts by email.

%d bloggers like this: